Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Agonist regulation of the expression of the delta opioid receptor in NG108-15 cells.

Kim DS, Chin H, Klee WA.

FEBS Lett. 1995 Nov 27;376(1-2):11-4.

2.

Regional expression and chromosomal localization of the delta opiate receptor gene.

Bzdega T, Chin H, Kim H, Jung HH, Kozak CA, Klee WA.

Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9305-9.

3.

Developmental expression of G proteins that differentially modulate adenylyl cyclase activity in mouse brain.

Rius RA, Streaty RA, Peng Loh Y, Klee WA.

FEBS Lett. 1991 Aug 19;288(1-2):51-4.

5.

Probes for narcotic receptor mediated phenomena. 15. (3S,4S)-(+)-trans-3-methylfentanyl isothiocyanate, a potent site-directed acylating agent for the delta opioid receptors in vitro.

Kim CH, Rothman RB, Jacobson AE, Mattson MV, Bykov V, Streaty RA, Klee WA, George C, Long JB, Rice KC.

J Med Chem. 1989 Jun;32(6):1392-8.

PMID:
2542560
6.

Development of opiate receptors and GTP-binding regulatory proteins in neonatal rat brain.

Milligan G, Streaty RA, Gierschik P, Spiegel AM, Klee WA.

J Biol Chem. 1987 Jun 25;262(18):8626-30.

7.

Comparison of (-)-eseroline with (+)-eseroline and dihydroseco analogues in antinociceptive assays: confirmation of rubreserine structure by X-ray analysis.

Schönenberger B, Jacobson AE, Brossi A, Streaty R, Klee WA, Flippen-Anderson JL, Gilardi R.

J Med Chem. 1986 Nov;29(11):2268-73.

PMID:
3023611
11.

Functional control of the delta-opiate receptor by the inhibitory guanine nucleotide-binding protein.

Milligan G, Simonds WF, Streaty RA, Tocque B, Klee WA.

Biochem Soc Trans. 1985 Dec;13(6):1110-3. No abstract available.

PMID:
3005079
12.

Purification of the opiate receptor of NG108-15 neuroblastoma-glioma hybrid cells.

Simonds WF, Burke TR Jr, Rice KC, Jacobson AE, Klee WA.

Proc Natl Acad Sci U S A. 1985 Aug;82(15):4974-8.

13.
14.

Adenylate cyclases in two populations of membranes purified from neuroblastoma X glioma hybrid (NG 108-15) cells.

Sweat FW, Klee WA.

J Cyclic Nucleotide Protein Phosphor Res. 1985;10(6):565-78.

PMID:
4086676
16.
17.

The role of adenyl cyclase in opiate tolerance and dependence.

Klee WA, Milligan G, Simonds WF, Tocque B.

NIDA Res Monogr. 1984;54:109-18. No abstract available.

PMID:
6152484
18.

On the mechanism of receptor-mediated inhibition of adenylate cyclase.

Klee WA, Koski G, Tocque B, Simonds WF.

Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984;17:153-9. No abstract available.

PMID:
6145318
19.

Photolabile opioid derivatives of D-Ala2-Leu5-enkephalin and their interactions with the opiate receptor.

Zioudrou C, Varoucha D, Loukas S, Nicolaou N, Streaty RA, Klee WA.

J Biol Chem. 1983 Sep 25;258(18):10934-7.

20.

Opioid activities and structures of alpha-casein-derived exorphins.

Loukas S, Varoucha D, Zioudrou C, Streaty RA, Klee WA.

Biochemistry. 1983 Sep 13;22(19):4567-73.

PMID:
6313043
21.

A new class of nonionic detergents with a gluconamide polar group.

Hjelmeland LM, Klee WA, Osborne JC Jr.

Anal Biochem. 1983 Apr 15;130(2):485-90.

PMID:
6869837
22.

Irreversible ligands with high selectivity toward delta and mu opiate receptors.

Rice KC, Jacobson AE, Burke TR Jr, Bajwa BS, Streaty RA, Klee WA.

Science. 1983 Apr 15;220(4594):314-6.

PMID:
6132444
23.

Probes for narcotic receptor mediated phenomena. 5. Narcotic antagonist irreversible ligands based on endoethenotetrahydrooripavine.

Jacobson AE, Bajwa BS, Streaty RA, Klee WA, Rice KC.

Life Sci. 1983;33 Suppl 1:159-62.

PMID:
6319854
24.

Identification of a Mr 58 000 glycoprotein subunit of the opiate receptor.

Klee WA, Simonds WF, Sweat FW, Burke TR Jr, Jacobson AE, Rice KC.

FEBS Lett. 1982 Dec 13;150(1):125-8.

26.

Photolabile ligands for opiate receptors.

Zioudrou C, Varoucha D, Loukas S, Streaty RA, Klee WA.

Life Sci. 1982 Oct 18-25;31(16-17):1671-4.

PMID:
6296569
27.

Opiates inhibit adenylate cyclase by stimulating GTP hydrolysis.

Koski G, Klee WA.

Proc Natl Acad Sci U S A. 1981 Jul;78(7):4185-9.

28.

Guanine nucleotides inhibit binding of agonists and antagonists to soluble opiate receptors.

Koski G, Simonds WF, Klee WA.

J Biol Chem. 1981 Feb 25;256(4):1536-8.

29.

Solubilization of opiate receptors from human placenta.

Ahmed MS, Byrne WL, Klee WA.

Placenta Suppl. 1981;3:115-21. No abstract available.

PMID:
6306641
30.

Opioid-dependent dual regulation of adenylate cyclase in a cell-free system.

Klee WA, Streaty RA.

Adv Cyclic Nucleotide Res. 1981;14:629-35. No abstract available.

PMID:
6269403
31.

Solubilization of active opiate receptors.

Simonds WF, Koski G, Streaty RA, Hjelmeland LM, Klee WA.

Proc Natl Acad Sci U S A. 1980 Aug;77(8):4623-7.

32.

Entry of opioid peptides into the central nervous system.

Rapoport SI, Klee WA, Pettigrew KD, Ohno K.

Science. 1980 Jan 4;207(4426):84-6.

PMID:
7350645
33.

Enkephalin generating activity of rat brain endopeptidases.

Knight M, Klee WA.

J Biol Chem. 1979 Oct 25;254(20):10426-30.

34.

Opioid peptides derived from food proteins. The exorphins.

Zioudrou C, Streaty RA, Klee WA.

J Biol Chem. 1979 Apr 10;254(7):2446-9.

35.

Paradoxical effects of N-cyanoalkyl substituents upon the activities of several classes of opioids.

Jacobson AE, Rice KC, Reden J, Lupinacci L, Brossi A, Streaty RA, Klee WA.

J Med Chem. 1979 Mar;22(3):328-31.

PMID:
218015
36.

Deoxymorphines: role of the phenolic hydroxyl in antinociception and opiate receptor interactions.

Reden J, Reich MF, Rice KC, Jacobson AE, Brossi A, Streaty RA, Klee WA.

J Med Chem. 1979 Mar;22(3):256-9.

PMID:
218012
37.

Opioid peptides as modulators of cyclic AMP levels.

Klee WA.

Adv Exp Med Biol. 1979;116:225-31. No abstract available.

PMID:
224671
38.

Drug actions mediated by changes in adenylate cyclase activity.

Klee WA.

Prog Clin Biol Res. 1979;27:219-25. No abstract available.

PMID:
218230
39.

Peptides of the central nervous system.

Klee WA.

Adv Protein Chem. 1979;33:243-86. Review. No abstract available.

PMID:
94507
40.

beta-Endorphin: modulation of acute tolerance and antagonism by endogenous brain systems.

Jacquet YF, Klee WA, Smyth DG.

Brain Res. 1978 Nov 10;156(2):396-401. No abstract available.

PMID:
213168
41.

The relationship between enkephalin degradation and opiate receptor occupancy.

Knight M, Klee WA.

J Biol Chem. 1978 Jun 10;253(11):3843-7. No abstract available.

42.

Stereospecific and nonstereospecific effects of (+)- and (-)-morphine: evidence for a new class of receptors?

Jacquet YF, Klee WA, Rice KC, Iijima I, Minamikawa J.

Science. 1977 Nov 25;198(4319):842-5.

PMID:
199942
43.

Effect of dehydration on the endogenous opiate content of the rat neuro-intermediate lobe.

Mata MM, Gainer H, Klee WA.

Life Sci. 1977 Oct 15;21(8):1159-62. No abstract available.

PMID:
916812
44.

Opiate-dependent modulation of adenylate cyclase.

Sharma SK, Klee WA, Nirenberg M.

Proc Natl Acad Sci U S A. 1977 Aug;74(8):3365-9.

45.

N-(2,4,5-Trihydroxyphenehtyl)normetazocine, a potential irreversible inhibitor of the narcotic receptor.

Rice KC, Shiotani S, Creveling CR, Jacobson AE, Klee WA.

J Med Chem. 1977 May;20(5):673-5.

PMID:
16133
47.
48.

Endorphin from pituitary inhibits cyclic AMP formation in homogenates of neuroblastoma X glioma hybrid cells.

Goldstein A, Cox BM, Klee WA, Nirenberg M.

Nature. 1977 Jan 27;265(5592):362-3. No abstract available.

PMID:
189215
49.

Mode of action of endogenous opiate peptides.

Klee WA, Nirenberg M.

Nature. 1976 Oct 14;263(5578):609-12. No abstract available.

PMID:
185523
50.

Tolerance and dependence evoked by an endogenous opiate peptide.

Lampert A, Nirenberg M, Klee WA.

Proc Natl Acad Sci U S A. 1976 Sep;73(9):3165-7.

Supplemental Content

Support Center